Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice
Farooq Syed, Olivia Ballew, Chih‐Chun Lee, Jyoti Rana, Preethi Krishnan, Ângela Castela, Staci A. Weaver, Namratha Shivani Chalasani, Sofia Thomaidou, Stéphane Demine, Garrick Chang, Alexandra Coomans de Brachène, Maria Inês Alvelos, Eugenia Martin Vázquez, Lorella Marselli, , Carmella Evans‐Molina
This study shows that TYK2 inhibitors reduce islet inflammation and delay type 1 diabetes onset in mice by modulating immune and endocrine responses.
EBioMedicine · May 6, 2025Peer-reviewedPhysiology